{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:43:09Z","timestamp":1788903789850,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-025-01120-2","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:52:19Z","timestamp":1761745939000},"page":"1955-1969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatio-temporal kinetics of patients\u2019 CAR-T cells in blood and serous cavity effusion: real-world clinical insights"],"prefix":"10.1007","volume":"48","author":[{"given":"Man","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuekun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"1120_CR1","first-page":"119","volume":"10","author":"S-M Dang","year":"2024","unstructured":"S.-M. Dang, D. Yang, Z.-Y. Wang, X.-M. Ding, X.-L. Li, D.-Y. Li, D.-X. Li, Vasculogenic mimicry: a pivotal mechanism contributing to drug resistance in antiangiogenic therapy. Oncol. Translational Med. 10, 119\u2013125 (2024)","journal-title":"Oncol. Translational Med."},{"key":"1120_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","volume":"106","author":"C Imai","year":"2005","unstructured":"C. Imai, S. Iwamoto, D. Campana, Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood. 106, 376\u2013383 (2005)","journal-title":"Blood"},{"key":"1120_CR3","doi-asserted-by":"publisher","first-page":"963689724123189","DOI":"10.1177\/09636897241231892","volume":"33","author":"J Han","year":"2024","unstructured":"J. Han, B. Zhang, S. Zheng, Y. Jiang, X. Zhang, K. Mao, The progress and prospects of immune cell therapy for the treatment of cancer. Cell. Transpl. 33, 9636897241231892 (2024)","journal-title":"Cell. Transpl."},{"key":"1120_CR4","doi-asserted-by":"publisher","first-page":"1869389","DOI":"10.1080\/2162402X.2020.1869389","volume":"10","author":"F Kast","year":"2021","unstructured":"F. Kast, C. Klein, P. Uma\u00f1a, A. Gros, S. Gasser, Advances in identification and selection of personalized neoantigen\/T-cell pairs for autologous adoptive T cell therapies. Oncoimmunology. 10, 1869389 (2021)","journal-title":"Oncoimmunology"},{"key":"1120_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"R.C. Sterner, R.M. Sterner, CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021)","journal-title":"Blood Cancer J."},{"key":"1120_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12943-022-01669-8","volume":"21","author":"C Qu","year":"2022","unstructured":"C. Qu, H. Zhang, H. Cao, L. Tang, H. Mo, F. Liu, L. Zhang, Z. Yi, L. Long, L. Yan, Z. Wang, N. Zhang, P. Luo, J. Zhang, Z. Liu, W. Ye, Z. Liu, Q. Cheng, Tumor buster - where will the CAR-T cell therapy \u2018missile\u2019 go? Mol. Cancer. 21, 201 (2022)","journal-title":"Mol. Cancer"},{"key":"1120_CR7","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41591-023-02404-6","volume":"29","author":"JH Park","year":"2023","unstructured":"J.H. Park, K. Nath, S.M. Devlin, C.S. Sauter, M.L. Palomba, G. Shah, P. Dahi, R.J. Lin, M. Scordo, M.A. Perales, R. Shouval, A.A. Tomas, E. Cathcart, E. Mead, B. Santomasso, A. Holodny, R.J. Brentjens, I. Riviere, M. Sadelain, CD19 CAR T-cell therapy and prophylactic Anakinra in relapsed or refractory lymphoma: phase 2 trial interim results. Nat. Med. 29, 1710\u20131717 (2023)","journal-title":"Nat. Med."},{"key":"1120_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.neo.7900209","volume":"4","author":"RJ Melder","year":"2002","unstructured":"R.J. Melder, L.L. Munn, B.R. Stoll, E.M. Marecos, L.T. Baxter, R. Weissleder, R.K. Jain, Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based Pharmacokinetic model. Neoplasia. 4, 3\u20138 (2002)","journal-title":"Neoplasia"},{"key":"1120_CR9","doi-asserted-by":"publisher","first-page":"20201013","DOI":"10.1098\/rsif.2020.1013","volume":"18","author":"LV Brown","year":"2021","unstructured":"L.V. Brown, E.A. Gaffney, A. Ager, J. Wagg, M.C. Coles, Quantifying the limits of CAR T-cell delivery in mice and men. J. R Soc. Interface. 18, 20201013 (2021)","journal-title":"J. R Soc. Interface"},{"key":"1120_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/CJI.0000000000000160","volume":"40","author":"JL Tanyi","year":"2017","unstructured":"J.L. Tanyi, C. Stashwick, G. Plesa, M.A. Morgan, D. Porter, M.V. Maus, C.H. June, Possible compartmental cytokine release syndrome in a patient with recurrent ovarian cancer after treatment with Mesothelin-targeted CAR-T cells. J. Immunother. 40, 104\u2013107 (2017)","journal-title":"J. Immunother"},{"key":"1120_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41467-019-13880-1","volume":"11","author":"A Sheih","year":"2020","unstructured":"A. Sheih, V. Voillet, L.A. Hanafi, H.A. Deberg, M. Yajima, R. Hawkins, V. Gersuk, S.R. Riddell, D.G. Maloney, M.E. Wohlfahrt, D. Pande, M.R. Enstrom, H.P. Kiem, J.E. Adair, R. Gottardo, P.S. Linsley, C.J. Turtle, Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy. Nat. Commun. 11, 219 (2020)","journal-title":"Nat. Commun."},{"key":"1120_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","volume":"6","author":"DT Teachey","year":"2016","unstructured":"D.T. Teachey, S.F. Lacey, P.A. Shaw, J.J. Melenhorst, S.L. Maude, N. Frey, E. Pequignot, V.E. Gonzalez, F. Chen, J. Finklestein, D.M. Barrett, S.L. Weiss, J.C. Fitzgerald, R.A. Berg, R. Aplenc, C. Callahan, S.R. Rheingold, Z. Zheng, S. Rose-John, J.C. White, F. Nazimuddin, G. Wertheim, B.L. Levine, C.H. June, D.L. Porter, S.A. Grupp, Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 6, 664\u2013679 (2016)","journal-title":"Cancer Discov"},{"key":"1120_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"S.L. Maude, T.W. Laetsch, J. Buechner, S. Rives, M. Boyer, H. Bittencourt, P. Bader, M.R. Verneris, H.E. Stefanski, G.D. Myers, M. Qayed, B. De Moerloose, H. Hiramatsu, K. Schlis, K.L. Davis, P.L. Martin, E.R. Nemecek, G.A. Yanik, C. Peters, A. Baruchel, N. Boissel, F. Mechinaud, A. Balduzzi, J. Krueger, C.H. June, B.L. Levine, P. Wood, T. Taran, M. Leung, K.T. Mueller, Y. Zhang, K. Sen, D. Lebwohl, M.A. Pulsipher, S.A. Grupp, Tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia. N Engl. J. Med. 378, 439\u2013448 (2018)","journal-title":"N Engl. J. Med."},{"key":"1120_CR14","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41591-019-0549-5","volume":"25","author":"S Ghorashian","year":"2019","unstructured":"S. Ghorashian, A.M. Kramer, S. Onuoha, G. Wright, J. Bartram, R. Richardson, S.J. Albon, J. Casanovas-Company, F. Castro, B. Popova, K. Villanueva, J. Yeung, W. Vetharoy, A. Guvenel, P.A. Wawrzyniecka, L. Mekkaoui, G.W. Cheung, D. Pinner, J. Chu, G. Lucchini, J. Silva, O. Ciocarlie, A. Lazareva, S. Inglott, K.C. Gilmour, G. Ahsan, M. Ferrari, S. Manzoor, K. Champion, T. Brooks, A. Lopes, A. Hackshaw, F. Farzaneh, R. Chiesa, K. Rao, D. Bonney, S.N. Samarasinghe, A. Goulden, P. Vora, R. Veys, R. Hough, M.A. Wynn, P.J. Pule, Amrolia, Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nat. Med. 25, 1408\u20131414 (2019)","journal-title":"Nat. Med."},{"key":"1120_CR15","doi-asserted-by":"crossref","unstructured":"R. Alaggio, C. Amador, I. Anagnostopoulos, A.D. Attygalle, I.B.O. Araujo, E. Berti, G. Bhagat, A.M. Borges, D. Boyer, M. Calaminici, A. Chadburn, J.K.C. Chan, W. Cheuk, W.J. Chng, J.K. Choi, S.S. Chuang, S.E. Coupland, M. Czader, S.S. Dave, D. De Jong, M.Q. Du, K.S. Elenitoba-Johnson, J. Ferry, J. Geyer, D. Gratzinger, J. Guitart, S. Gujral, M. Harris, C.J. Harrison, S. Hartmann, A. Hochhaus, P.M. Jansen, K. Karube, W. Kempf, J. Khoury, H. Kimura, W. Klapper, A.E. Kovach, S. Kumar, A.J. Lazar, S. Lazzi, L. Leoncini, N. Leung, V. Leventaki, X.Q. Li, M.S. Lim, W.P. Liu, A. Jr. Louissaint, A. Marcogliese, L.J. Medeiros, M. Michal, R.N. Miranda, C. Mitteldorf, S. Montes-Moreno, W. Morice, V. Nardi, K.N. Naresh, Y. Natkunam, S.B. Ng, I. Oschlies, G. Ott, M. Parrens, M. Pulitzer, S.V. Rajkumar, A.C. Rawstron, K. Rech, A. Rosenwald, J. Said, C. Sarkozy, S. Sayed, C. Saygin, A. Schuh, W. Sewell, R. Siebert, A.R. Sohani, R. Tooze, A. Traverse-Glehen, F. Vega, A.D. Vergier, B. Wechalekar, L. Wood, Xerri, W. Xiao, The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 36, 1720\u20131748 (2022)","DOI":"10.1038\/s41375-022-01620-2"},{"key":"1120_CR16","doi-asserted-by":"crossref","unstructured":"J.D. Khoury, E. Solary, O. Abla, Y. Akkari, R. Alaggio, J.F. Apperley, R. Bejar, E. Berti, L. Busque, J.K.C. Chan, W. Chen, X. Chen, W.J. Chng, J.K. Choi, I. Colmenero, S.E. Coupland, N.C.P. Cross, D. De Jong, M.T. Elghetany, E. Takahashi, J.F. Emile, J. Ferry, L. Fogelstrand, M. Fontenay, U. Germing, S.T. Gujral, C. Haferlach, J.C. Harrison, S. Hodge, J.H. Hu, R. Jansen, H.M. Kanagal-Shamanna, C.P. Kantarjian, X.Q. Kratz, M.S. Li, K. Lim, S. Loeb, A. Loghavi, S. Marcogliese, P. Meshinchi, K.N. Michaels, Y. Naresh, R. Natkunam, G. Nejati, E. Ott, K.P. Padron, N. Patel, J. Patkar, U. Picarsic, I. Platzbecker, A. Roberts, R. Schuh, P. Siebert, J. Tembhare, S. Tyner, W. Verstovsek, B. Wang, C. Wood, A. Yeung, Hochhaus, The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 36, 1703-1719 (2022)","DOI":"10.1038\/s41375-022-01613-1"},{"key":"1120_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1378\/chest.12-1292","volume":"143","author":"MP Moy","year":"2013","unstructured":"M.P. Moy, J.M. Levsky, N.S. Berko, A. Godelman, V.R. Jain, L.B. Haramati, A new, simple method for estimating pleural effusion size on CT scans. Chest. 143, 1054\u20131059 (2013)","journal-title":"Chest"},{"key":"1120_CR18","doi-asserted-by":"crossref","unstructured":"O. Hunsicker, C. Fotopoulou, K. Pietzner, M. Koch, A. Krannich, J. Sehouli, C. Spies, A. Feldheiser, Hemodynamic consequences of malignant Ascites in epithelial ovarian cancer Surgery*: A prospective substudy of a randomized controlled trial. Med. (Baltim). 94, e2108 (2015)","DOI":"10.1097\/MD.0000000000002108"},{"key":"1120_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"D.W. Lee, B.D. Santomasso, F.L. Locke, A. Ghobadi, C.J. Turtle, J.N. Brudno, M.V. Maus, J.H. Park, E. Mead, S. Pavletic, W.Y. Go, L. Eldjerou, R.A. Gardner, N. Frey, K.J. Curran, K. Peggs, M. Pasquini, J.F. Dipersio, M.R.M. Van Den Brink, K.V. Komanduri, S.A. Grupp, S.S. Neelapu, ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol. Blood Marrow Transpl. 25, 625\u2013638 (2019)","journal-title":"Biol. Blood Marrow Transpl."},{"key":"1120_CR20","doi-asserted-by":"crossref","unstructured":"D.W. Lee, R. Gardner, D.L. Porter, C.U. Louis, N. Ahmed, M. Jensen, S.A. Grupp, C.L. Mackall, Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 124, 188\u2009\u2013\u2009195 (2014)","DOI":"10.1182\/blood-2014-05-552729"},{"key":"1120_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jmoldx.2020.02.007","volume":"22","author":"Y Lou","year":"2020","unstructured":"Y. Lou, C. Chen, X. Long, J. Gu, M. Xiao, D. Wang, X. Zhou, T. Li, Z. Hong, C. Li, J. Zhou, L. Chen, Detection and quantification of chimeric antigen receptor transgene copy number by droplet digital PCR versus Real-Time PCR. J. Mol. Diagn. 22, 699\u2013707 (2020)","journal-title":"J. Mol. Diagn."},{"key":"1120_CR22","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1182\/blood.2020008936","volume":"137","author":"D Wang","year":"2021","unstructured":"D. Wang, J. Wang, G. Hu, W. Wang, Y. Xiao, H. Cai, L. Jiang, L. Meng, Y. Yang, X. Zhou, Z. Hong, Z. Yao, M. Xiao, L. Chen, X. Mao, L. Zhu, J. Wang, L. Qiu, C. Li, J. Zhou, A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed\/refractory multiple myeloma. Blood. 137, 2890\u20132901 (2021)","journal-title":"Blood"},{"key":"1120_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood.2019000017","volume":"135","author":"N Wang","year":"2020","unstructured":"N. Wang, X. Hu, W. Cao, C. Li, Y. Xiao, Y. Cao, C. Gu, S. Zhang, L. Chen, J. Cheng, G. Wang, X. Zhou, M. Zheng, X. Mao, L. Jiang, D. Wang, Q. Wang, Y. Lou, H. Cai, D. Yan, Y. Zhang, T. Zhang, J. Zhou, L. Huang, Efficacy and safety of CAR19\/22 T-cell cocktail therapy in patients with refractory\/relapsed B-cell malignancies. Blood. 135, 17\u201327 (2020)","journal-title":"Blood"},{"key":"1120_CR24","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/bcp.14281","volume":"86","author":"N Dasyam","year":"2020","unstructured":"N. Dasyam, P. George, R. Weinkove, Chimeric antigen receptor T-cell therapies: optimising the dose. Br. J. Clin. Pharmacol. 86, 1678\u20131689 (2020)","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1120_CR25","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1182\/blood.2021013733","volume":"139","author":"Y Qi","year":"2022","unstructured":"Y. Qi, M. Zhao, Y. Hu, Y. Wang, P. Li, J. Cao, M. Shi, J. Tan, M. Zhang, X. Xiao, J. Xia, S. Ma, J. Qiao, Z. Yan, H. Li, B. Pan, W. Sang, D. Li, Z. Li, J. Zhou, H. Huang, A. Liang, J. Zheng, K. Xu, Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL. Blood. 139, 3376\u20133386 (2022)","journal-title":"Blood"},{"key":"1120_CR26","doi-asserted-by":"crossref","unstructured":"L. Ding, Y. Hu, K. Zhao, G. Wei, W. Wu, Z. Wu, L. Xiao, H. Huang, Pleural cavity cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy: A case report. Med. (Baltim). 97, e9992 (2018)","DOI":"10.1097\/MD.0000000000009992"},{"key":"1120_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","volume":"24","author":"M Norelli","year":"2018","unstructured":"M. Norelli, B. Camisa, G. Barbiera, L. Falcone, A. Purevdorj, M. Genua, F. Sanvito, M. Ponzoni, C. Doglioni, P. Cristofori, C. Traversari, C. Bordignon, F. Ciceri, R. Ostuni, C. Bonini, M. Casucci, A. Bondanza, Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med. 24, 739\u2013748 (2018)","journal-title":"Nat. Med."},{"key":"1120_CR28","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1182\/blood-2017-06-786129","volume":"130","author":"KT Mueller","year":"2017","unstructured":"K.T. Mueller, S.L. Maude, D.L. Porter, N. Frey, P. Wood, X. Han, E. Waldron, A. Chakraborty, R. Awasthi, B.L. Levine, J.J. Melenhorst, S.A. Grupp, C.H. June, S.F. Lacey, Cellular kinetics of CTL019 in relapsed\/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blood. 130, 2317\u20132325 (2017)","journal-title":"Blood"},{"key":"1120_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","volume":"385","author":"DW Lee","year":"2015","unstructured":"D.W. Lee, J.N. Kochenderfer, M. Stetler-Stevenson, Y.K. Cui, C. Delbrook, S.A. Feldman, T.J. Fry, R. Orentas, M. Sabatino, N.N. Shah, S.M. Steinberg, D. Stroncek, N. Tschernia, C. Yuan, H. Zhang, L. Zhang, S.A. Rosenberg, A.S. Wayne, C.L. Mackall, T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet. 385, 517\u2013528 (2015)","journal-title":"Lancet"},{"key":"1120_CR30","doi-asserted-by":"crossref","unstructured":"S.R. Rheingold, L.N. Chen, S.L. Maude, R. Aplenc, C. Barker, D.M. Barrett, C. Callahan, K. Cebry, I. Kulikovskaya, S.F. Lacey, B.L. Levine, J.J. Melenhorst, P.A. Shaw, A. Sparrow, D.T. Teachey, M. Duckworth, C.H. June, S.A. Grupp, Efficient Trafficking of Chimeric Antigen Receptor (CAR)-Modified T Cells to CSF and Induction of Durable CNS Remissions in Children with CNS\/Combined Relapsed\/Refractory ALL. Blood. 126, 3769 (2015)","DOI":"10.1182\/blood.V126.23.3769.3769"},{"key":"1120_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","volume":"21","author":"JN Brudno","year":"2024","unstructured":"J.N. Brudno, J.N. Kochenderfer, Current Understanding and management of CAR T cell-associated toxicities. Nat. Rev. Clin. Oncol. 21, 501\u2013521 (2024)","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1120_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"Global","year":"2024","unstructured":"Global, regional, and National burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet Neurol. 23, 344\u2013381 (2024)","journal-title":"Lancet Neurol."},{"key":"1120_CR33","doi-asserted-by":"crossref","unstructured":"T.E. Gofton, G.B. Young, Sepsis-associated encephalopathy. Nat. Rev. Neurol. 8, 557\u2009\u2013\u200966 (2012)","DOI":"10.1038\/nrneurol.2012.183"},{"key":"1120_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13054-021-03659-6","volume":"25","author":"MC Barbosa-Silva","year":"2021","unstructured":"M.C. Barbosa-Silva, M.N. Lima, D. Battaglini, C. Robba, P. Pelosi, P.R.M. Rocco, Maron-Gutierrez, infectious disease-associated encephalopathies. Crit. Care. 25, 236 (2021)","journal-title":"Crit. Care"},{"key":"1120_CR35","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1016\/S2352-3026(21)00238-6","volume":"8","author":"AB Leahy","year":"2021","unstructured":"A.B. Leahy, H. Newman, Y. Li, H. Liu, R. Myers, A. Dinofia, J.G. Dolan, C. Callahan, D. Baniewicz, K. Devine, L. Wray, R. Aplenc, C.H. June, S.A. Grupp, S.R. Rheingold, S.L. Maude, CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials. Lancet Haematol. 8, e711\u2013e22 (2021)","journal-title":"Lancet Haematol."},{"key":"1120_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-020-00256-x","volume":"5","author":"J Wei","year":"2020","unstructured":"J. Wei, Y. Liu, C. Wang, Y. Zhang, C. Tong, G. Dai, W. Wang, J.E.J. Rasko, J.J. Melenhorst, W. Qian, A. Liang, W. Han, The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma. Signal. Transduct. Target. Ther. 5, 134 (2020)","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1120_CR37","doi-asserted-by":"publisher","first-page":"707191","DOI":"10.3389\/fimmu.2021.707191","volume":"12","author":"C Luan","year":"2021","unstructured":"C. Luan, J. Zhou, H. Wang, X. Ma, Z. Long, X. Cheng, X. Chen, Z. Huang, D. Zhang, R. Xia, J. Ge, Case report: local cytokine release syndrome in an acute lymphoblastic leukemia patient after treatment with chimeric antigen receptor T-Cell therapy: A possible Model, literature review and perspective. Front. Immunol. 12, 707191 (2021)","journal-title":"Front. Immunol."},{"key":"1120_CR38","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41409-018-0412-1","volume":"54","author":"A Jin","year":"2019","unstructured":"A. Jin, J. Feng, Z. Wang, L. Jiang, Y. Hu, K. Zhao, H. Huang, Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed\/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy. Bone Marrow Transpl. 54, 969\u2013972 (2019)","journal-title":"Bone Marrow Transpl."},{"key":"1120_CR39","doi-asserted-by":"publisher","first-page":"114421","DOI":"10.1016\/j.addr.2022.114421","volume":"188","author":"T Qi","year":"2022","unstructured":"T. Qi, K. Mcgrath, R. Ranganathan, G. Dotti, Y. Cao, Cellular kinetics: A clinical and computational review of CAR-T cell Pharmacology. Adv. Drug Deliv Rev. 188, 114421 (2022)","journal-title":"Adv. Drug Deliv Rev."},{"key":"1120_CR40","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","volume":"33","author":"JN Kochenderfer","year":"2015","unstructured":"J.N. Kochenderfer, M.E. Dudley, S.H. Kassim, R.P. Somerville, R.O. Carpenter, M. Stetler-Stevenson, J.C. Yang, G.Q. Phan, M.S. Hughes, R.M. Sherry, M. Raffeld, S. Feldman, L. Lu, Y.F. Li, L.T. Ngo, A. Goy, T. Feldman, D.E. Spaner, M.L. Wang, C.C. Chen, S.M. Kranick, A. Nath, D.A. Nathan, K.E. Morton, M.A. Toomey, S.A. Rosenberg, Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J. Clin. Oncol. 33, 540\u2013549 (2015)","journal-title":"J. Clin. Oncol."},{"key":"1120_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ccm.2016.01.013","volume":"37","author":"A Mazeraud","year":"2016","unstructured":"A. Mazeraud, Q. Pascal, F. Verdonk, N. Heming, F. Chr\u00e9tien, T. Sharshar, Neuroanatomy and physiology of brain dysfunction in sepsis. Clin. Chest Med. 37, 333\u2013345 (2016)","journal-title":"Clin. Chest Med."},{"key":"1120_CR42","first-page":"392","volume":"17","author":"A Mazeraud","year":"2020","unstructured":"A. Mazeraud, C. Righy, E. Bouchereau, S. Benghanem, F.A. Bozza, T. Sharshar, Septic-Associated Encephalopathy: Compr. Rev. Neurother. 17, 392\u2013403 (2020)","journal-title":"Septic-Associated Encephalopathy: Compr. Rev. Neurother."},{"key":"1120_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1586\/eri.12.159","volume":"11","author":"N Adam","year":"2013","unstructured":"N. Adam, S. Kandelman, J. Mantz, F. Chr\u00e9tien, T. Sharshar, Sepsis-induced brain dysfunction. Expert Rev. Anti Infect. Ther. 11, 211\u2013221 (2013)","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"1120_CR44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13054-023-04655-8","volume":"27","author":"R Sonneville","year":"2023","unstructured":"R. Sonneville, S. Benghanem, L. Jeantin, E. De Montmollin, M. Doman, A. Gaudemer, M. Thy, J.F. Timsit, The spectrum of sepsis-associated encephalopathy: a clinical perspective. Crit. Care. 27, 386 (2023)","journal-title":"Crit. Care"},{"key":"1120_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","volume":"35","author":"UH Langen","year":"2019","unstructured":"U.H. Langen, S. Ayloo, C. Gu, Development and cell biology of the Blood-Brain barrier. Annu. Rev. Cell. Dev. Biol. 35, 591\u2013613 (2019)","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"1120_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"B.V. Zlokovic, The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 57, 178\u2013201 (2008)","journal-title":"Neuron"},{"key":"1120_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"M.D. Sweeney, Z. Zhao, A. Montagne, A.R. Nelson, B.V. Zlokovic, Blood-Brain barrier: from physiology to disease and back. Physiol. Rev. 99, 21\u201378 (2019)","journal-title":"Physiol. Rev."},{"key":"1120_CR48","doi-asserted-by":"crossref","unstructured":"I. Galea, The blood-brain barrier in systemic infection and inflammation. Cell Mol. Immunol. 18, 2489\u2009\u2013\u20092501 (2021)","DOI":"10.1038\/s41423-021-00757-x"},{"key":"1120_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10571-008-9322-x","volume":"29","author":"T Nishioku","year":"2009","unstructured":"T. Nishioku, S. Dohgu, F. Takata, T. Eto, N. Ishikawa, K.B. Kodama, S. Nakagawa, A. Yamauchi, Y. Kataoka, Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell. Mol. Neurobiol. 29, 309\u2013316 (2009)","journal-title":"Cell. Mol. Neurobiol."},{"key":"1120_CR50","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1158\/2159-8290.CD-17-1368","volume":"8","author":"A Taraseviciute","year":"2018","unstructured":"A. Taraseviciute, V. Tkachev, R. Ponce, C.J. Turtle, J.M. Snyder, H.D. Liggitt, D. Myerson, L. Gonzalez-Cuyar, A. Baldessari, C. English, A. Yu, H. Zheng, S.N. Furlan, D.J. Hunt, V. Hoglund, O. Finney, H. Brakke, B.R. Blazar, C. Berger, S.R. Riddell, R. Gardner, L.S. Kean, M.C. Jensen, Chimeric antigen receptor T Cell-Mediated neurotoxicity in nonhuman primates. Cancer Discov. 8, 750\u2013763 (2018)","journal-title":"Cancer Discov"},{"key":"1120_CR51","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41467-018-02912-x","volume":"9","author":"C Han","year":"2018","unstructured":"C. Han, S.J. Sim, S.H. Kim, R. Singh, S. Hwang, Y.I. Kim, S.H. Park, K.H. Kim, D.G. Lee, H.S. Oh, S. Lee, Y.H. Kim, B.K. Choi, B.S. Kwon, Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression. Nat. Commun. 9, 468 (2018)","journal-title":"Nat. Commun."},{"key":"1120_CR52","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-15-0139","volume":"75","author":"HG Caruso","year":"2015","unstructured":"H.G. Caruso, L.V. Hurton, A. Najjar, D. Rushworth, S. Ang, S. Olivares, T. Mi, K. Switzer, H. Singh, H. Huls, D.A. Lee, A.B. Heimberger, R.E. Champlin, L.J. Cooper, Tuning sensitivity of CAR to EGFR density limits recognition of normal tissue while maintaining potent antitumor activity. Cancer Res. 75, 3505\u20133518 (2015)","journal-title":"Cancer Res."},{"key":"1120_CR53","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1182\/blood-2009-08-232967","volume":"114","author":"SE James","year":"2009","unstructured":"S.E. James, N.N. Orgun, T.F. Tedder, M.J. Shlomchik, M.C. Jensen, Y. Lin, P.D. Greenberg, O.W. Press, Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice. Blood. 114, 5454\u20135463 (2009)","journal-title":"Blood"},{"key":"1120_CR54","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1084\/jem.20182375","volume":"216","author":"M Cazaux","year":"2019","unstructured":"M. Cazaux, C.L. Grandjean, F. Lema\u00eetre, Z. Garcia, R.J. Beck, I. Milo, J. Postat, J.B. Beltman, E.J. Cheadle, P. Bousso, Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity. J. Exp. Med. 216, 1038\u20131049 (2019)","journal-title":"J. Exp. Med."},{"key":"1120_CR55","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1182\/blood-2016-04-711903","volume":"128","author":"SA Ali","year":"2016","unstructured":"S.A. Ali, V. Shi, I. Maric, M. Wang, D.F. Stroncek, J.J. Rose, J.N. Brudno, M. Stetler-Stevenson, S.A. Feldman, B.G. Hansen, V.S. Fellowes, F.T. Hakim, R.E. Gress, J.N. Kochenderfer, T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. Blood. 128, 1688\u20131700 (2016)","journal-title":"Blood"},{"key":"1120_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nm.4441","volume":"24","author":"TJ Fry","year":"2018","unstructured":"T.J. Fry, N.N. Shah, R.J. Orentas, M. Stetler-Stevenson, C.M. Yuan, S. Ramakrishna, P. Wolters, S. Martin, C. Delbrook, B. Yates, H. Shalabi, T.J. Fountaine, J.F. Shern, R.G. Majzner, D.F. Stroncek, M. Sabatino, Y. Feng, D.S. Dimitrov, L. Zhang, S. Nguyen, H. Qin, B. Dropulic, D.W. Lee, C.L. Mackall, CD22-targeted CAR T cells induce remission in B-ALL that is Naive or resistant to CD19-targeted CAR immunotherapy. Nat. Med. 24, 20\u201328 (2018)","journal-title":"Nat. Med."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01120-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:05:39Z","timestamp":1765447539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01120-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1120"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01120-2","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (TJ-IRB202407126). Informed consent was obtained from the patients in strict accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}